We help institutional investors and crypto-natives get exposure to DeFi investment opportunities. Avantgardeās purpose-built platform provides a unique layer on top of Enzyme to enable the creation of compliant DeFi investment products that can be scaled at low cost
We are Avantgarde. The technologists, analysts and catalysts of on-chain asset management, optimised with the tools and expertise that put your imagination in control. As the core contributor to the Enzyme protocol, we utilise our experience in both DeFi and traditional finance to build products and services on top of Enzyme, the DeFi Operating System.
We’re building on-chain investment products to take DeFi usage from billions to trillions. To achieve this means making DeFi accessible to a range of audiences: institutional investors, family offices, hedge funds, crypto funds and HNWIs.
Through a combination of boundless thinking and unprecedented rigour, we help our clients achieve radical impact – whatever the mandate.
Our crypto fund platform is built on the robust Enzyme protocol, which provides access to digital assets and DeFi from one simple, unified app. Thanks to the operational and administrative innovations of on-chain asset management, our model offers: A reduction in the total expense ratios of funds by 80% or more On-chain......